Intermediate stage treatment: Is TACE enough?

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|1|187-187

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.1, 2018-01, pp. : 187-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Response to Intermediate stage treatment: Is TACE enough?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 188-189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 141-147

Karger

Access to resources Recommend Favorite

Treatment Strategies of Intermediate-Stage Hepatocellular Carcinomas in Japan (Barcelona Clinic Liver Cancer Stage B)

By  

Oncology, Vol. 87, Iss. 1, 2014-11 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 19-26

Karger

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite